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The H-2 gene complex of the mouse can be divided into four regions, K, I, S, and D (1, 2). 
The K and D regions control the classical H-2 antigens which are detected serologically by 
serum  antibodies,  and  also  by  graft  rejection.  The  S  region  contains  the  genes  which 
regulate the Ss and Slp protein variants in the serum (3). The I region contains immune 
response (Ir) genes, which regulate the antibody responses to many antigens, both natural 
and synthetic (4). 
It  has  recently  been  shown  that  genes  responsible  for  the  strongest  reactions  in 
graft-vs.-host (5) and mixed leukocyte reaction (MLR) ~ (6, 7) map in the I region; weaker 
MLR reactions can be caused by the K or D regions alone. Differences in the I region can 
also result in graft rejection (8;  Shreffler,  unpublished  observations). 
Recently, we have described an antiserum  directed against antigens  mapping in the I 
region  of the  H-2  complex  (9-11).  These  antigens  originally  named  Lna  (9),  are  now 
designated Ia (I region-associated antigens)  (32). Similar antigen systems also mapping in 
this  region have  been described  by others  (12-14). Ir genes are thought to be expressed 
primarily in T  cells (4,  16),  although effects in B cells can be demonstrated  (17-19). If Ia 
antigens were related to Ir products they would be expected to be expressed on T cells, but 
also perhaps on B cells. The original reports of David et al. (9), Hauptfeld et al.  (12), and 
GStze et  al.  (14)  suggested that  Ia antigens  were expressed  on T  cells.  Later reports by 
Sachs and Cone (13) and Hammerling et al. (15) reported that the antigens were expressed 
exclusively on B  cells. 
In this report,  we describe further studies on the cellular distribution  of antigens 
detected  by our original  antiserum,  A.TH  anti-A.TL,  and  evidence  for specific 
reactions  with  T  lymphocytes,  as  well  as  B  lymphocytes,  as  detected  by  a 
sensitive  microcytotoxic test. 
* Supported  by U.S.  Public  Health  Service  Program Project  2-P01-GM-15419-07 and  Damon 
Runyon DRG-1260 and NIH Grant R01-AI-11962-01. 
Fellow of the Jane Coffin Childs  Memorial  Fund for Medical  Research. 
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Materials  and Methods 
Mice were raised in our colony at the University of Michigan. A.TH mice are H-2 "~ (K  s I  s S  ~  D  d) and 
A.TL mice  are H-2  t~  (K  ~ I  k S  k D  d)  (9). BALB/cdJ  (H-2  ~)  mice were purchased from the Jackson 
Laboratories,  Bar Harbor, Maine. BALB/c nude mice were raised from N7 nu/+ breeders which were 
a  generous  gift  of Dr.  E.  A.  Boyse. A.TH anti-A.TL antiserum was drawn from two large pools 
prepared as previously described (9). Anti-Thy-1  b was prepared  by immunization  of AKR mice with 
C3H thymocytes according  to Reif and Allen (20) (50% titer with C3H thymus cells  =  1/2,560}. 
Mouse-specific B lymphocyte antigen (MBLA) was prepared as previously described by Niederhuber 
(21) (50% titer with bone marrow cells 1/32). Dye exclusion microcytotoxic tests were done as pre- 
viously described  (9), except  that nigrosin was subsituted for trypan blue for the visualization of 
dead cells, and the cell number in each well was decreased to 700. 
In vivo absorptions were performed as previously described (22). In vitro absorptions were done by 
adding 100 pl of appropriately diluted antiserum to a counted number of packed absorbing cells. After 
1 h  at  room  temperature, the suspension  was centrifuged  and the supernate tested for residual 
antibody activity. For  absorptions using thymocytes,  care  was taken to  exclude  the  parathymic 
lymph nodes. 
To test the effect of anti-Ia serum on plaque-forming cells (PFC), mouse spleen cells primed with 
sheep red blood cells (SRBC) were obtained by injection of 4 × l0  s SRBC 6 days before sacrifice. This 
preparation was treated with anti-Thy-1  b, and two concentrations of anti-Ia sera in the presence of 
complement. The remaining cells were plaqued with SRBC by the method of Jerne (23). 
To determine if anti-Ia, anti-Thy-1, and anti-MBLA were reacting with different cell populations, 
equal volumes of each of the appropriate antisera (Ia, Thy-1, MBLA) were mixed in such a manner 
that the concentration of each antiserum was equivalent to that used in the unmixed sera. These 
mixed sera were assayed for their cytotoxic effects on normal cell populations. T cells were purified on 
nylon wool columns by the method of Julius et al. (24). Cortisone-resistant thymocytes were prepared 
by intraperitoneal injection of 10 mg cortisone, 48 h before sacrifice (25). These cells are thought to be 
a more mature population of T cells than normal thymocytes.  A C57Br{H-2  *) Gross ~irus-induced 
thymic leukemia L251A, grown in tissue culture, was supplied by Dr. Ronald T. Acton, University of 
Alabama, Birmingham, Ala. (33). 
Results 
Assay.  The  cytotoxic  test  in  use  in  our  laboratory  has  been  modified  in 
several ways to increase its sensitivity. The use of medium 199 in place of Hanks' 
balanced salt solution which, we have found, allows the use of higher concentra- 
tions of rabbit complement, along with a two-stage test in which the complement 
incubation is done in the absence of fetal calf serum, have together increased the 
sensitivity of this test to an extremely high level. Many of the reactions described 
are  not  detectable  using  either  a  51Cr-release  or  a  standard  semimicro  dye 
exclusion test done in tubes. 
Direct  Cytotoxic  Test.  We  had  previously  reported,  using A.TL  or  A.TH 
lymph node lymphocytes at  low antiserum concentration (dilutions of 1/500 or 
greater), a  maximum  cytotoxicity of 50%. As can be seen in Fig. 1, the maximum 
kill  at  high  serum  concentration with  A.TL  lymph  node  cells  is  70%,  but  a 
distinct and reproducible  biphasic titration curve is seen,  the titer of the first 
break  being  approximately  1/100.  Beyond  this  point,  the  level  of  killing of 
approximately 50%  persists to  the  end point of the  titration. Direct tests  with 
splenic lymphocytes  (Fig.  2)  also  show  a  similar biphasic titration curve,  but 
generally  a  lower  maximum  percentage  kill  (50-60%)  and  a  lower  plateau  of 
killing (20-30%)  than  lymph  node  lymphocytes.  Thymus  cell  targets  act  in  a FRELINGER,  NIEDERHUBER,  DAVID,  AND  SHREFFLER  1275 
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FIG.  I.  Direct cytotoxic test of A.TH anti A.TL  (A--A)  tested with A.TL lymph node target 
cells;  ATH  normal serum (O---O). 
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Direct  cytotoxic  test  of  A.TH  anti  A.TL  tested  with  A.TL  splenic  lymphocytes. 
weak,  irregularly reproducible manner,  in direct tests,  occasionally resulting in 
up to 20% killing (10% above baseline) with titers up to 1/1,000. 
Cortisone-resistant  thymocytes,  which  were  greater  than  95%  sensitive  to 
anti-Thy-1 b serum, when tested with anti-Ia serum gave killing in the range of 
30-50%, with titers comparable to lymph node and spleen cells (Fig. 3). However, 
these cells fail to demonstrate the pronounced biphasic titration curve observed 
with lymph node and spleen  cell targets.  When T  cells were purified on nylon 
wool columns (Leukopak, Fenwal Laboratories, Morton Grove, Ill.), enrichment 
of Thy-lb-positive  cells  from  spleen  from  30%  up  to  80%  was obtained.  From 
lymph nodes a more modest enrichment of T  cells from 65 to about 75-80% was 
achieved. The yield of Thy-lb-positive cells from spleen was about 80-90%, while 
from  lymph  nodes  it was  only  40-50%.  These values  are  comparable  to  those 
reported  by  Julius  (24).  Cortisone-resistant  thymus  cells  were  also  passed 
through  the column to ascertain  the  effects of the column on a relatively pure 
(95%)  T-cell  population.  When  purified T  cells from these  three  sources were 
tested in the cytotoxic test with the A.TH anti-A.TL serum, none were reactive, 
including the column purified cortisone-resistant thymocytes. 
In  most  of  these  experiments,  it  was  possible  to  account  for  the  loss  of 
Ia-positive cells by simple retention on the column. In other experiments it was 
necessary to postulate a conversion from Ia-positive to Ia-negative  after passage 1276  Ia ON  T  CELLS 
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FIG. 3.  Direct  cytotoxic test of A.TH anti A.TL (A--A)  tested with A.TL cortisone-resistant 
thymus  cells;  ATH  normal  serum  (Q--O). 
through  the  nylon  wool  column.  For  example,  in  one  experiment  1.8  x  107 
Ia-positive lymph node  cells  in  a  total  of 2.6  x  107  cells were placed  on the 
column. As  a  maximum estimate, 3  x  l0 B  Ia-positive cells were recovered in a 
total of 1.6  x  107  cells recovered. This leaves  1.5  x  107 Ia-positive cells to be 
accounted for,  but only 107  cells were retained on the column. This implies a 
minimum  conversion of 5  x  10 ~ Ia-positive cells to Ia-negative. This does not 
seem to be a function of simple incubation of the cells in median, because cells 
held  for  similar  lengths  of time  in  tissue  culture  median  alone  do  not  lose 
expression of Ia antigens. 
Expression of Ia Antigens on Tumors.  Several tumors,  both T- and B-cell- 
derived,  and  several  tumor  cell  lines  have  been  screened  for  reactivity with 
anti-Ia  sera.  These  include  L  251A  (C57Br/cdJ,  H-2~),  H  111  (AKR/J,  H-2  ~) 
HA4995  (AKR/J,  H-2~),  EL-4  (C57BL/10,  H-2b),  IB  (C58,  H-2k),  Meth  A 
(BALB/cJ,  H-2d).  Only  L  251A  was  positive.  This  is  a  Gross  virus-induced 
lymphoma derived from strain  C57Br/cdJ  (H-2~).  Both anti-Ia and anti-Thy-1 
sera kill  100% of these cells (Fig. 4). This shows that at least some T-cell tumor 
lines do express both Ia and Thy-1 antigens. 
Effects of Anti-Ia Serum on PFC.  A.AL (K  k I k S k D ~) cells are equivalent to 
A.TL  cells  in  reactivity with  A.TH  anti-A.TL.  Spleen  cells  from  A.AL  mice 
which had been immunized with SRBC were treated with normal rabbit serum as 
a  complement source, anti-Thy-1, and  anti-Ia  1/100  and 1/1,000. The cytotoxic 
index of each of these preparations is  noted as  follows:  defining the  cytotoxic 
index for the  complement control as  0,  the  CI  for anti-Thy-1 was  27;  anti-Ia 
1/100,  55,  and  anti-Ia  1/1,000,  25.  The  residual  concentration  of  PFC  was 
determined after each treatment (Fig. 5). Anti-Thy-1  b, and anti-Ia (1/1,000) gave 
no  decrease  in  the  PFC  concentrations  in  spite  of appreciable  cytotoxicity. 
Anti-Ia at  1/100 did diminish the number of PFC by approximately 50%. 
Absorptions.  Repeated  attempts  to  achieve  specific  absorption  of  A.TH 
anti-A.TL serum  at  concentrations greater than  1/100  were unsuccessful. With 
serum concentrations of 1/200,  the serum  was absorbed equally well by lymph 
node or spleen cells, but lymph node targets seemed to be generally slightly more 
sensitive to residual cytotoxic activity than spleen cells (Fig. 6 a and b). Normal 
thymus  cells  could  also  absorb  this  activity,  but  less  effectively than  either 
lymph  node  or  splenic  lymphocytes.  Cortisone-resistant  thymocytes were  as FRELINGER,  NIEDERHUBER,  DAVID, AND SHREFFLER 
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FIG.  4.  Direct cytotoxic test of A.TH anti A.TL (O--O), and AKR anti C3H (n--I]) tested 
with C57Br leukemic cell line L251A. 
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FIG. 5.  Effect of anti-Ia serum on PFC. A.AL spleen cells primed in vivo with 2 × l0 s SRBC 5 
days before testing. The normal bar represents unimmunized spleen. 
effective  in  absorptions  as  spleen  or  lymph  node  cells.  BALB/c-nu/nu  mice 
(NTF1) were injected with undiluted A.TH anti-A.TL serum and bled after 2, 6, 
and 24 h. The resulting in vivo absorbed serum was tested for residual activity 
against nude and normal BALB/c lymph node cells and against cortisone-resist- 
ant BALB/c thymocytes. The resulting titration curve with normal lymph node 
targets  is  shown  in  Fig.  7.  This  serum  was  unreactive  with  nude  cells,  but 
contained residual  activity against  both normal BALB/c lymph node cells and 
cortisone-resistant thymocytes, both at 2 and 6 h after injection. After 24 to 30 h, 1278 
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FIG.  6.  (a) Absorption test of A.TH anti A.TL. Serum was absorbed with A.TH spleen cells 
(A--A). A.TL  lymph node  cells  (O  .... O),  A.TL spleen cells  (m---B)  (bottom),  or A.TL 
thymus (D--D) or cortisone-resistant  thymus (0---0) (top), and tested with A.TL lymph node 
lymphocyte targets. (b) Same sera tested with A.TL spleen cells. FRELINGER,  NIEDERHUBER,  DAVID, AND SHREFFLER 
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FIG. 7.  In vivo absorption of A.TH anti A.TL in BALB/c nudes. Tested with normal BALB/c 
lymph node lymphocytes. Upper curve before absorption, lower after absorption. Plotted to 
correct for the dilution in vivo. 
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no  detectable  antibody remained,  however.  Normal BALB/c mice completely 
cleared equal amounts of anti-A.TL serum for all targets by 2-3 h. 
Mixed Antiserum Experiments.  These experiments were similar in design to 
those of Raft (26) to test for restriction of reactivity to a single class of cells. A.TH 
anti-A.TL serum was mixed with anti-Thy-1  b serum or anti-MBLA serum and 
tested with A.TL lymph node targets. The effects of the mixed antisera were 
compared with the effects of each of the antisera tested separately on the same 
cell  preparation.  The  results  are  shown  in  Table  I.  When  anti-Thy-1  and 
anti-MBLA were mixed, all lymph node cells were killed. When low concentra- 
tions of anti-Ia (1/1,000)  and Thy-1 were mixed, little additive killing resulted. 
However, when anti-MBLA and anti-Ia (1/1,000)  were mixed, a marked increase 
in  killing  resulted.  In  order  to  test  for  possible  interference  by  non-Thy-1 
antibodies in the anti-Thy-1 serum, the reciprocal antiserum, C3H anti-AKR, 
was  tested  with  A.AL,  a  Thy-1  a  strain,  in  similar  mixing experiments  with 
similar results.  Similar experiments were also performed with ATL anti-ATH 
and anti-Thy-1  b with similar results. In contrast, when similar experiments were 
performed using higher anti-Ia serum concentration additive killing results with 
both anti-MBLA and anti-Thy-1. In order to determine if some simple form of 
allelic exclusion was operating (A × B10.S)FI lymph node cells were tested with 
anti-Ia  B (A.TL-a-A.TH),  anti-Ia  k  (A.TH-a-A.TL)  and  mixtures  of  the  two 
antisera. If some simple form of allelic exclusion was operating then an increase 
in the toxicity of either antiserum alone would be expected. As shown in Table I, 
even the mixtures of the antisera do not show 100% killing. In fact there is no 
increase  over  the  maximum killing  of either  antiserum  alone.  This  provides 
evidence that Ia antigens are present only on a  subset of lymphocytes and that 
no simple form of allelic exclusion is operating. 
Discussion 
The  central  question  we  have  been  addressing  is  whether  Ia  antigens  are 1280  I a ON T CELLS 
TABLE I 
Relationship  of Ia  to Thy-1  and MBLA Antigens 
Antisera 
Percent killing of target cells*: 
A.TL LNC:~  A.AL  LNC§  A.TH LNCI[  (A X B10.S)FI$ 
Anti-Thy-  1 (  1/32)**  60  60  65  65 
Anti-MBLA (1/2)  40  45  40  30 
Anti-Ia (1/1,000)$$  50  50  50  50 
Anti-Ia (1/50)  70  70  70  70 
Anti-Thy-1 + anti-la (1/1,000)  60  65  70  70 
Anti-Thy-1 + anti-Ia (1/50)  > 90  ND  ND  ND 
Anti-MBLA + anti-Ia (1/1,000)  >95  >90  90  90 
Anti-MBLA + anti-Thy- 1  > 95  100  > 95  90 
Anti-Ia  k + anti-Ia ~  ND  ND  ND  70 
* LNC, lymph node cells. 
P, Thy-l.2. 
§ P, Thy-l.1. 
I[ P, Thy-l.2. 
** Anti-Thy-l.2  (AKR/J anti-C3H/J)  was  used for  all  tests, except against A.AL LNC, where 
anti-Thy-l.1  (C3H/J anti-AKR/J) was used. 
~  Anti-P (A,TH anti-A.TL) was used for all tests, except against A.TH LNC, where anti-Ia s (A.TL 
anti-A.TH) was used. 
expressed on B  cells or T  cells or both. The 70%  levels of cytotoxicity observed 
using lymph node targets,  coupled with the 40% levels of B cells in lymph nodes 
{26),  make restriction of Ia antigens to the B  cell unlikely. Likewise, the 50-60% 
cytotoxicity  of  spleen  cells  makes  a  restriction  to  T  cells  also  unlikely. 
Hammerling (15)  has reported that the reactivity of an almost identical  anti-Ia 
serum (B10.S  ×  A.TH)-~-(B10.S  ×  A.TL) is restricted to B  lymphocytes. Sachs 
has  reported a  similar but  much lower-titered  anti-B-cell serum  (13).  Our own 
antiserum reacts not only with 70% of lymph node lymphocytes but with 40-50% 
of cortisone-resistant thymocytes. The cortisone-resistant thymocytes are greater 
than  95%  sensitive  to  anti-Thy-P  sera.  These  data  clearly  demonstrate  the 
reactivity of this anti-Ia serum with some population of T  cells. Further, a T-cell 
(Thy-l-positive) tumor has  also been found which is killed  by the  anti-Ia sera. 
Interestingly, when T  cells from either spleen, lymph node, or cortisone-resistant 
thymus are purified by passage through nylon wool column, these T  cells are no 
longer reactive with anti-Ia serum. Two experiments are particularly revealing. 
The  finding  that  the  nylon  column  selectively  eliminates  reactive  cortisone 
resistant thymocytes may imply that the Ia-positive T  cells are simply removed. 
However, the experiments  in which recoveries are sufficiently high demonstrate 
not  simply  a  depletion  of  Ia-positive  cells,  but  a  probable  conversion  of 
Ia-sensitive  to  Ia-insensitive  cells.  This  capacity  of  cells  to  convert  from 
anti-Ia-sensitive to Ia-insensitive may have important implications for attempts 
to determine the function of Ia antigens on lymphocyte surfaces by adding anti-Ia 
sera  to block lymphocyte function  in  vitro in  experiments  in which nylon fiber 
purified cells are used as a  source of T  cells. FRELINGER, NIEDERHUBER, DAVID, AND SHREFFLER  1281 
The Ia-reactivity of up to 60% of spleen cells from normal mice, the reactions of 
anti-Ia serum with nude spleen and lymph node cells, and the killing of PFC by 
anti-Ia sera,  all unequivocally confirm the presence of Ia antigens on B cells, as 
found by Hammerling et al.  (15) and Sachs and  Cone (13). 
The  next  important  question  is whether  the T-  and  B-cell reactivities were 
caused by one or two discrete antibody populations. The biphasic titration curve 
is suggestive of two discrete  antibody  populations,  each  reacting  with  its own 
antigen.  This suggestion is given further support by the single phase curve and 
high titer of cortisone-resistant thymocytes. Further support for this interpreta- 
tion is generated by the following arguments.  If there are present in the serum a 
high titered anti-T-cell antibody and a lower titered anti-B-cell antibody, then at 
low serum concentration  (high  dilution)  the serum would appear specific for T 
cells.  The  prediction  would  then  be  for  additive  killing  of  anti-Ia  with 
anti-MBLA, but not with anti-Thy-P.  When the anti-Ia serum was used at low 
concentration  that  is, of course, what was observed. It would also be predicted 
that  at low concentrations,  anti-Ia  reactivity could be absorbed by T  cells. As 
shown, the anti-Ia serum was absorbed both by cortisone-resistant  and normal 
thymus,  although less efficiently by normal thymus. 
Another prediction of the two antibody-two antigen model would be that nude 
mice  should  be  able  to  absorb  the  anti-B-cell  activity  without  removing  the 
anti-T-cell  reaction.  This  was  also observed.  Sera  absorbed  in  nudes  retained 
activity both against  cortisone-resistant thymus and normal cells. The observa- 
tion  that  PFC  are  killed  by high  but not  low concentrations  of anti-Ia,  even 
though the entire cell population shows significant cytotoxicity at low concentra- 
tions,  is also consistent. 
Two  observations  seem  to  argue  against  these  interpretations.  First,  the 
titration curve with nude lymph node and spleen target cells is high titered. Since 
nude  mice  have  few  functional  T  cells,  this  suggests  that  the  high-titered 
antibody  is  also  directed  at  B  cells.  The  second  observation  is  that  after 
absorption  in vivo for 24 h,  nude mice completely removed activity for normal 
BALB/c lymphocytes. In other anti-Ia absorptions, as well as with anti-H-2D or 
H-2K,  antibodies  not removed by 6  h  are  not usually  absorbed by 24 h.  This 
suggests that all of the antibodies can really be absorbed by B cells, although the 
antibody population  most reactive with T  cells is less efficiently absorbed. An 
alternative  interpretation  of these observations stems from recent observations 
that nude mice often have small but detectable numbers of T  cells (26,  28) and 
increased numbers of peripheral T-cell precursors (29). If the antigen is expressed 
in nudes, either on the T cells present in low numbers, or on the T-cell precursors 
at  low density,  they  might  still  be detectable by our  sensitive  cytotoxic test. 
These  cells  might  react  like  mature  T  cells on  direct  test,  even  though  their 
absorptive capacity might be much lower than normal cells. This would explain 
the slow in vivo absorption by nudes for T  cells; but their rapid absorption of the 
B-cell  antibody.  Yet  another  explanation  is  that  the  affinity  of  the  T-cell 
antibody is lower for B  cells so that  absorption of the T-cell antibody by nude 
cells is not efficient. This would also explain the slow absorption by nudes. 
We have described above the tissue distribution of the Ia antigens and found 1282  Ia ON T CELLS 
them to be present on both T  and B  cells. Further suggestive evidence has been 
presented  indicating  that  there  may be two discrete  antibody populations,  one 
specific for T cells and one for B  cells. It is not yet known if any of the individual 
specificities thus far assigned in the Ia system (30, 31) are restricted to either T  or 
B  cells.  The  possible functions  of these  antigens  remain to be determined.  Are 
they  the  MLR  determinants,  or  perhaps  the  T-B-cell  recognition  structures 
suggested  by  Katz  et  al.  (18)?  Are  they  the  T-cell antigen  receptors?  Work  is 
underway  to  attempt  to  answer  these  questions  and  to  further  define  the 
function(s)  of the Ia antigens. 
Summary 
We have  demonstrated  in  an  anti-Ia serum  the  presence of specific antibodies 
reacting  with  T  cells,  as  well  as  with  B  cells,  using  a  highly  sensitive  dye 
exclusion  test.  This  antiserum  reacts  with  both  spleen  and  lymph  node  in  a 
characteristic  biphasic  titration  curve  killing  up  to  70%  of these  cells.  It  also 
reacts  with  cortisone-resistant  thymocytes.  The  A.TH-a-A.TL  serum  can  be 
absorbed with spleen, lymph node, cortisone-resistant thymus, or normal thymus 
cells.  Further  in  vivo  absorptions  in  BALB/c  nude  cannot  remove  all  of the 
cytotoxic activity for normal BALB lymph node lymphocytes, while completely 
removing the  activity for nude  cells.  A  Thy-1  positive cell  line  derived  from a 
C57Br leukemia is reactive with this anti-Ia serum. 
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